These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

155 related articles for article (PubMed ID: 6342936)

  • 1. Thermal stability of a long-acting analogue of luteinizing hormone releasing hormone (D-trp6-pro9-NEt-LHRH).
    Winterer J; Chatterji D; Comite F; Decker MH; Loriaux DL; Gallelli JF; Cutler GB
    Contraception; 1983 Feb; 27(2):195-200. PubMed ID: 6342936
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The luteinizing hormone-releasing hormone (LHRH) agonist [D-Trp6-Pro9-NEt]LHRH increased rather than lowered LH and alpha-subunit levels in a patient with an LH-secreting pituitary tumor.
    Roman SH; Goldstein M; Kourides IA; Comite F; Bardin CW; Krieger DT
    J Clin Endocrinol Metab; 1984 Feb; 58(2):313-9. PubMed ID: 6198331
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of the luteinizing hormone-releasing hormone (LHRH) analog D-Trp6-Pro9-NEt-LHRH on the pituitary-gonadal axis of prepubertal rhesus monkeys.
    Cassorla F; Renquist D; Barnard D; Munabi AK; Cutler GB; Loriaux DL
    Biol Reprod; 1984 Jun; 30(5):1130-4. PubMed ID: 6428479
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Gonadotropin and steroid secretory patterns during chronic treatment with a luteinizing hormone-releasing hormone agonist analog in men.
    Evans RM; Doelle GC; Alexander AN; Uderman HD; Rabin D
    J Clin Endocrinol Metab; 1984 May; 58(5):862-7. PubMed ID: 6423661
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Direct effect of the luteinizing hormone releasing hormone analog D-Trp6-Pro9-Net-LHRH on rat ovarian steroidogenesis.
    Malozowski S; Cassorla F; Gelato M; Nicoletti M; D'Agata R; Mericq V; Loriaux D
    Horm Metab Res; 1985 Jun; 17(6):321-2. PubMed ID: 3894195
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of pituitary-testicular axis suppression in utero and during the early neonatal period with a long-acting luteinizing hormone-releasing hormone analog on genital development, somatic growth, and bone density in male cynomolgus monkeys in the first 6 months of life.
    Liu L; Cristiano AM; Southers JL; Reynolds JC; Bacher J; Brown G; Gilley RM; Tice TR; Banks SM; Loriaux LD
    J Clin Endocrinol Metab; 1991 Nov; 73(5):1038-43. PubMed ID: 1939516
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Maintenance of the ratio of bioactive to immunoreactive follicle-stimulating hormone in normal men during chronic luteinizing hormone-releasing hormone agonist administration.
    Pavlou SN; Dahl KD; Wakefield G; Rivier J; Vale W; Hsueh AJ; Lindner J
    J Clin Endocrinol Metab; 1988 May; 66(5):1005-9. PubMed ID: 2834409
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A luteinizing hormone-releasing hormone agonist decreases biological activity and modifies chromatographic behavior of luteinizing hormone in man.
    Evans RM; Doelle GC; Lindner J; Bradley V; Rabin D
    J Clin Invest; 1984 Jan; 73(1):262-6. PubMed ID: 6228566
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Luteinizing hormone releasing hormone analogue therapy for central precocious puberty. Long-term effect on somatic growth, bone maturation, and predicted height.
    Comite F; Cassorla F; Barnes KM; Hench KD; Dwyer A; Skerda MC; Loriaux DL; Cutler GB; Pescovitz OH
    JAMA; 1986 May; 255(19):2613-6. PubMed ID: 3084811
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Therapeutic use of pituitary desensitization with a long-acting lhrh agonist: a potential new treatment for idiopathic precocious puberty.
    Crowley WF; Comite F; Vale W; Rivier J; Loriaux DL; Cutler GB
    J Clin Endocrinol Metab; 1981 Feb; 52(2):370-2. PubMed ID: 6780592
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of luteinizing hormone releasing hormone (LHRH) and [D-Trp6, des-Gly-NH2(10)]LHRH ethylamide on alpha-subunit and LH beta messenger ribonucleic acid levels in rat anterior pituitary cells in culture.
    Hubert JF; Simard J; Gagné B; Barden N; Labrie F
    Mol Endocrinol; 1988 Jun; 2(6):521-7. PubMed ID: 2458526
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Radioimmunoassay of [D-Trp6]-luteinizing hormone-releasing hormone: its application to animal pharmacokinetic studies after single injection and long-acting formulation administration.
    Ezan E; Drieu K; Chapelat M; Rougeot C; Dray F
    Regul Pept; 1986 Apr; 14(2):155-67. PubMed ID: 2940625
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of [D-Trp6]LHRH infusion on prolactin secretion by perifused rat pituitary cells.
    Torres-Aleman I; Fernández M; Debeljuk L; Charro AL
    Regul Pept; 1987 Jul; 18(1):19-28. PubMed ID: 2957725
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Direct effect of the luteinizing hormone releasing hormone analog D-Trp6-Pro9-Net-LHRH on rat testicular steroidogenesis.
    D'Agata R; Cassorla F; Munabi AK; Mericq V; Gelato MC; Albertson BD; Loriaux DL
    Steroids; 1984 Feb; 43(2):201-7. PubMed ID: 6395451
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Sensitivity differences in reproductive/endocrine organs to chronically administered LHRH agonists in female rats.
    Phillips A; Hahn DW; Klimek S; McGuire JL; Crowley WF
    Life Sci; 1987 Apr; 40(14):1379-89. PubMed ID: 3550346
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mice are insensitive to the antitesticular effects of luteinizing hormone-releasing hormone agonists.
    Wang NG; Sundaram K; Pavlou S; Rivier J; Vale W; Bardin CW
    Endocrinology; 1983 Jan; 112(1):331-5. PubMed ID: 6291919
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of deslorelin dose in the treatment of central precocious puberty.
    Pescovitz OH; Barnes KM; Cutler GB
    J Clin Endocrinol Metab; 1991 Jan; 72(1):60-4. PubMed ID: 1898743
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The NIH experience with precocious puberty: diagnostic subgroups and response to short-term luteinizing hormone releasing hormone analogue therapy.
    Pescovitz OH; Comite F; Hench K; Barnes K; McNemar A; Foster C; Kenigsberg D; Loriaux DL; Cutler GB
    J Pediatr; 1986 Jan; 108(1):47-54. PubMed ID: 3080571
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Heterogeneity of sperm density profiles following 16-week therapy with continuous infusion of high-dose LHRH analog plus testosterone.
    Pavlou SN; Interlandi JW; Wakefield G; Rivier J; Vale W; Rabin D
    J Androl; 1986; 7(4):228-33. PubMed ID: 3528106
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Direct inhibition of testicular steroidogenesis and gonadotrophin receptor levels by [(imBzl)-D-His6, Pro9-NEt]GnRH and [D-Trp6, Pro9-NEt]GnRH, potent agonists of GnRH.
    Cao YQ; Sundaram K; Bardin CW; Rivier J; Vale W
    Int J Androl; 1982 Apr; 5(2):158-70. PubMed ID: 6286508
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.